EUVIMEDEUVIMED entdecken
Crossref

Boswellic Acid-Integrated Chitosan Hybrid Nanogels for pH-Responsive Sustained Sunitinib Release and Lung Tumor Suppression

Zahra Amiri, Mehdi Jahanbakhshi iD, Mohsen Momeni, Ehsan Heidary, Shaghayegh AdibAmini iD, Tara Hassani Goodarzi, Arian Karimi Rouzbahani, Zahra Haghighatian, Yavuz Nuri Ertas iD, Bahareh Farasati Far iD

ACS Applied Materials & Interfaces · 2026

DOI: 10.1021/acsami.6c02925 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Applied Materials & Interfaces, 2026. Verfasst von Zahra Amiri und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Nanotechnology, School of Medicine, North Khorasan University of Medical Sciences, Bojnurd94149, Iran. Hauptthemen laut MEDLINE: Chitosan, Sunitinib, Lung Neoplasms, Triterpenes. Die Arbeit nennt 47 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Stimuli-responsive chitosan-based nanogels have attracted significant interest for drug delivery; however, many reported systems rely on synthetic crosslinkers and function primarily as passive carriers with limited control over network architecture and molecular transport. Here, we report a boswellic-acid-integrated, pH-responsive hybrid nanogel platform in which boswellic acid serves as a bioactive network modifier and hydrophobic domain-forming component within chitosan matrices. Chitosan-boswellic acid (CS-g-BOS) hydrogel precursors were first formed via formaldehyde-assisted network formation and subsequently converted into CS-g-BOS nanogels via STPP-mediated ionic condensation, yielding a shear-thinning porous hydrogel precursor and pH-responsive nanogels relevant to injectable formulation development. The triterpenoid constituents of BOS contribute to the formation of a heterogeneous network, introducing hydrophobic domains that regulate mesh size and diffusion pathways. Comprehensive physicochemical characterization (1H NMR, FTIR, SEM, AFM, DLS, zeta potential, thermal stability, and rheological analyses) showed that BOS incorporation altered nanogel morphology, swelling behavior, rheological response, and release kinetics. The nanogels exhibited high sunitinib encapsulation efficiency (95.52%) and sustained, pH-dependent drug release over 18 days, with accelerated release under acidic tumor-mimicking conditions. Among the tested kinetic models, the Korsmeyer–Peppas model provided the best fit, suggesting that sunitinib malate (SUN) release is diffusion-dominated and modulated by pH-dependent swelling of the CS-g-BOS network. In vitro studies demonstrated cytotoxic and apoptosis-inducing activity against A549 human lung cancer cells, while hemolysis assays indicated favorable blood compatibility. Mouse xenograft studies showed tumor growth suppression, and the chick CAM assay demonstrated antiangiogenic activity; however, histological alterations in the liver, lungs, and kidneys indicated that systemic safety requires further optimization. Overall, this work presents a bio-derived hybrid-network strategy that integrates nanogel network engineering, transport control, and therapeutic functionality, offering a scalable alternative to conventional chitosan nanogels for tumor-responsive drug delivery applications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ChitosanSunitinibLung NeoplasmsTriterpenesNanogelsAntineoplastic AgentsHumansHydrogen-Ion ConcentrationAnimalsMiceDrug LiberationDrug CarriersDelayed-Action PreparationsA549 Cells

Stichwörter der Autor:innen

boswellic acidchitosanlung cancernanogelpH-responsive releasesunitinib

Substanzen

ChitosanSunitinibboswellic acidTriterpenesNanogelsAntineoplastic AgentsDrug CarriersDelayed-Action Preparations

Autor:innen und Institutionen

  • Department of Medical Nanotechnology, School of Medicine, North Khorasan University of Medical Sciences, Bojnurd94149, Iran.
  • School of Chemical Engineering, College of Engineering, University of Tehran, Tehran1417935840, Iran.
  • Cancer Metabolism and Tumor Microenvironment Group, Laboratory of Tumor and Development Biology, GIGA-Cancer, University of Liège, Liège4000, Belgium.
  • Department of Infectious Diseases and Geographic Medicine, Stanford University School of Medicine, Stanford, CA94305, United States of America.
  • Plasma Physics Research Center, Science and Research Branch, Islamic Azad University, Tehran1477893855, Iran.
  • Jiann-Ping Hsu College of Public Health, Georgia Southern University, Statesboro, GA30460, United States of America.

ORCID-Profile: Mehdi Jahanbakhshi, Shaghayegh AdibAmini, Yavuz Nuri Ertas, Bahareh Farasati Far

Zitieren

APA

Amiri, Z., Jahanbakhshi, M., Momeni, M., Heidary, E., AdibAmini, S., Goodarzi, T. H., Rouzbahani, A. K., Haghighatian, Z., Ertas, Y. N., & Far, B. F. (2026). Boswellic Acid-Integrated Chitosan Hybrid Nanogels for pH-Responsive Sustained Sunitinib Release and Lung Tumor Suppression. ACS Applied Materials & Interfaces. https://doi.org/10.1021/acsami.6c02925

Vancouver

Amiri Z, Jahanbakhshi M, Momeni M, Heidary E, AdibAmini S, Goodarzi TH, et al. Boswellic Acid-Integrated Chitosan Hybrid Nanogels for pH-Responsive Sustained Sunitinib Release and Lung Tumor Suppression. ACS Applied Materials & Interfaces. 2026. doi:10.1021/acsami.6c02925

BibTeX
@article{Amiri2026,
  author = {Amiri, Zahra and Jahanbakhshi, Mehdi and Momeni, Mohsen and Heidary, Ehsan and AdibAmini, Shaghayegh and Goodarzi, Tara Hassani and Rouzbahani, Arian Karimi and Haghighatian, Zahra and Ertas, Yavuz Nuri and Far, Bahareh Farasati},
  title = {Boswellic Acid-Integrated Chitosan Hybrid Nanogels for pH-Responsive Sustained Sunitinib Release and Lung Tumor Suppression},
  journal = {ACS Applied Materials & Interfaces},
  year = {2026},
  doi = {10.1021/acsami.6c02925}
}
Kostenlos starten →